GlassScriptPhysician profile
Tsung Peter Wong
NPI 1073513156
$11,938.21
in general payments reported to CMS, 2019-2025
42 companies · $1,703 in 2025
The $1,703 reported for 2025 was more than what 94% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,924 · 2020: $1,255 · 2021: $2,283 · 2022: $1,894 · 2023: $1,268 · 2024: $1,612 · 2025: $1,703.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,524 · Education: $58.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,523.74 |
| Education | $58.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,673.62 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Astrazeneca Pharmaceuticals LP | $1,350.51 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Abbvie INC. | $1,245.58 | 2019-2025 | Ubrelvy |
| Pfizer INC. | $1,059.81 | 2019-2025 | |
| Novo Nordisk INC | $962.53 | 2019-2025 | Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $883.07 | 2019-2024 | Jardiance |
| Paratek Pharmaceuticals, INC. | $739.37 | 2021-2025 | Nuzyra |
| Amarin Pharma, INC. | $463.09 | 2019-2022 | |
| Lilly USA, LLC | $322.43 | 2020-2025 | Jardiance, Mounjaro |
| Vanda Pharmaceuticals INC. | $319.07 | 2020-2024 | Hetlioz, Fanapt |
| Otsuka America Pharmaceutical, INC. | $288.56 | 2023-2025 | Rexulti |
| Ibsa Pharma INC. | $249.98 | 2022-2024 | Licart |
| Merck Sharp & Dohme LLC | $204.30 | 2019-2023 | Dificid, Belsomra |
| Exact Sciences Corporation | $195.97 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Allergan, INC. | $167.22 | 2019 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tsung Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.